Severe genotype, pancreatic insufficiency and low dose of pancreatic enzymes associate with abnormal serum sterol profile in cystic fibrosis
Drzymała-Czyż S. Krzyżanowska-Jankowska P. Dziedzic K. Lisowska A. Kurek S. Goździk-Spychalska J. Kononets V. Woźniak D. Mądry E. Walkowiak J.
February 2021MDPI AG
Biomolecules
2021#11Issue 21 - 16 pp.
Background: Several factors could lead to lipid disturbances observed in cystic fibrosis (CF). This study aimed to assess sterol homeostasis in CF and define potential exogenous and endogenous determinants of lipid dysregulation. Methods: The study involved 55 CF patients and 45 healthy subjects (HS). Sterol concentrations (µg/dL) were measured by gas chromatography/mass spectrometry. CF was characterised by lung function, pancreatic status, liver disease and diabetes coexistence, Pseudomonas aeruginosa colonisation and BMI. CFTR genotypes were classified as severe or other. Results: Campesterol and β-sitosterol concentrations were lower (p = 0.0028 and p < 0.0001, respectively) and lathosterol levels (reflecting endogenous cholesterol biosynthesis) were higher (p = 0.0016) in CF patients than in HS. Campesterol and β-sitosterol concentrations were lower in patients with a severe CFTR genotype, pancreatic insufficiency and lower pancreatic enzyme dose (lipase units/gram of fat). In multiple regression analyses, β-sitosterol and campesterol concentrations were predicted by genotype and pancreatic insufficiency, whereas cholesterol and its fractions were predicted by phytosterol concentrations, age, dose of pancreatic enzymes, nutritional status and genotype. Conclusions: Independent determinants of lipid status suggest that malabsorption and pancreatic enzyme supplementation play a significant role in sterol abnormalities. The measurement of campesterol and β-sitosterol concentrations in CF patients may serve for the assessment of the effectiveness of pancreatic enzyme replacement therapy and/or compliance, but further research is required.
Campesterol , Cholesterol , Lathosterol , Stigmasterol , β-sitosterol
Text of the article Перейти на текст статьи
Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznań, 60-572, Poland
Department of Bromatology, Poznan University of Medical Sciences, Poznań, 60-354, Poland
Department of Food Science and Nutrition, Institute of Food Technology of Plant Origin, Poznań University of Life Sciences, Poznań, 60-637, Poland
Department of Pulmonology, Allergology and Respiratory Oncology, Poznan University of Medical Sciences, Poznań, 60-569, Poland
Department of Natural Sciences Disciplines, West Kazakhstan Marat Ospanov Medical University, Aktobe, 030012, Kazakhstan
Department of Physiology, Poznan University of Medical Sciences, Poznań, 61-781, Poland
Department of Pediatric Gastroenterology and Metabolic Diseases
Department of Bromatology
Department of Food Science and Nutrition
Department of Pulmonology
Department of Natural Sciences Disciplines
Department of Physiology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026